• Juva Life (JUVA) is commencing commercial cannabis cultivation at its Stockton, California facility
  • The planting program is underway within the dedicated flowering rooms at its 30,000 sq. ft. facility
  • The cultivation team anticipates each room to deliver a full harvest five times per year
  • The Stockton facility also includes a delivery, packaging, and distribution center
  • From cultivation to consumer, Juva Life takes a knowledge-driven approach to advance the therapeutic effects of cannabis
  • Juva Life (JUVA) opened trading at C$1.95 per share

Juva Life (JUVA) is commencing commercial cannabis cultivation at its Stockton, California facility.

Subsequent to state licensing approval in January, the Juva cultivation team quickly concluded preparatory efforts for plant delivery this week. After 30 months of development effort, Juva Life has entered a vitally important phase of its business development with this week’s planting program now underway within the dedicated flowering rooms at its 30,000 sq. ft. facility.

The cultivation team anticipates each room to deliver a full harvest five times per year. Once all five rooms are functional, operational scheduling calls for a harvest every twelve days with an anticipated combined annual output of 6,000 pounds of high-quality cannabis flower.

Juva Life’s Stockton facility also includes a delivery, packaging, and distribution center. The growing cannabis delivery fleet offers nearly 400 product SKU’s across San Joaquin County with expansion plans into the surrounding region later this year. The separate distribution center will manage B2B shipments of bulk cannabis and future distribution of Juva branded products.

Company Founder and CEO, Doug Chloupek states, “It has been a long time coming, but I’ve always been confident we’d get here as planned.

Needless to say, I’m really pleased to finally have our plants in the ground. We can now count the days to increased revenues through commercial sales, and the ability to help fund our life sciences programs which will ultimately lead to an entire class of new proprietary products. We have entered an especially important part of our value proposition. Today marks the day we move beyond development-stage into a commercial enterprise.”

From cultivation to consumer, Juva Life takes a knowledge-driven approach to advance the therapeutic effects of cannabis.

Juva Life (JUVA) opened trading at C$1.95 per share.

More From The Market Online

Tilray’s Breckenridge Brewery honours Denver Nuggets with new ale

Tilray Brands (TSX:TLRY) subsidiary Breckenridge Brewery launches a new ale to recognize the 2023 NBA championship-winning Denver Nuggets.

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

Organigram looks to raise capital as cannabis stocks surge

Organigram (TSX:OGI), one of Canada's first cannabis stocks, announces an overnight marketed public offering of units for up to C$25 million.